DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Tully DC, Rucker PV, Chianelli D. et al.
Discovery of tropifexor (LJN452), a highly potent non-bile acid FXR agonist for the treatment of cholestatic liver diseases and nonalcoholic steatohepatitis (NASH).
J Med Chem 2017;
60 (24) 9960-9973
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.